Excella GmbH in Feucht, Germany has met the criteria established under the SafeBridge program for Potent Compound Safety Certification and has been deemed competent and proficient in the safe handling of potent APIs and potent drug products for the manufacture of oral solid dosage (OSD) forms. Excella is the first company worldwide to achieve SafeBridge Potent Compound Safety Certification for the manufacture of OSD forms.

SafeBridge conducted a 60-element review of health and safety programs, procedures, containment and exposure control of OSD operations with potent APIs at the company’s site and has certified that Excella meets current industry standards for the safe handling of potent APIs in the identified areas.